Skip to content

Monoject 1180325100Recalls & reported problems

Cardinal Health, Inc. · 3 mL Syringe with Standard Hypodermic Needle · Class 2

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10884521012431), received between Mar 6, 2024 and Mar 6, 2024 — classified as 1 malfunction.

The most frequently reported specific device problem is “Fluid/Blood Leak” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 1 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Fluid/Blood Leak1

Patient problems

  • Hemorrhage/Blood Loss/Bleeding1
  • Pain1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 6, 2024Fluid/Blood Leak; Fluid/Blood Leak

    THE CUSTOMER REPORTED THAT THE DEVICE CAME APART AND EXPLODED THE MEDICATION ALL OVER THE PLACE. THE CUSTOMER STATED THAT THE NEEDLE SEPARATED FROM THE SYRINGE AND REMAINED INSIDE WHILE THE MEDICATION (TRT) SHOT OUT EVERYWHERE. ADDITIONAL INFORMATION RECEIVED ON 29FEB2024 STATED THAT THE PATIENT SELF-ADMINISTERS TESTOSTERONE REPLACEMENT THERAPY (TRT) SO THIS WAS A SELF INJECTION, INTRA-MUSCULAR. THE HUB AND NEEDLE REMAINED SECURELY ATTACHED TO EACH OTHER, BUT THE HUB SEPARATED FROM THE SYRINGE, THE MEDICATION WAS IMMEDIATELY PUSHED OUT OF THE SYRINGE. THE NEEDLE AND HUB (TOGETHER) REMAINED INSIDE THE PATIENT AND WAS PULLED FROM THE INJECTION SITE MANUALLY BY GRASPING THE HUB AND PULLING THE NEEDLE OUT. THERE WAS NO SIGNIFICANT INJURY, ONLY A FAILED INJECTION, WASTED MEDICATION (ONE DOSE), MILD PAIN AT INJECTION SITE, AND MINIMAL BLEEDING.

    Patient problems: Hemorrhage/Blood Loss/Bleeding; Pain

    MAUDE report 18853050 ↗

Other Syringe, piston devices

All Syringe, piston devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.